Home › Funds › AQR › AQR CVX Fusion Fund
Fund family: AQR · Filed by AQR Funds (CIK 1444822) · SEC series S000093172
Share classes and tickers: QCFIX (C000261312), QCFNX (C000261314), QCFRX (C000261313)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 8,426 with, 291 against, 0 abstentions (not counted as with management); 73 items carried no recommendation; 2 split votes are in neither count. Shareholder proposals: 98 FOR, 244 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as AQR’s manager page (154,191 ballot items across 25 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | AQR | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 95.0% | 7,429 | 93.7% | 128,774 |
| Backed environmental and social shareholder proposals at US companies | 10.0% | 60 | 12.7% | 1,101 |
Each ballot item this fund voted is set against the votes of the other AQR funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most AQR funds on all 8,070 items where a comparison was possible.
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 5,028 | 6 |
| Corporate Governance | 1,133 | 132 |
| Compensation | 906 | 17 |
| Capital Structure | 693 | 7 |
| Audit-related | 543 | 0 |
| Say-on-Pay | 297 | 0 |
| Environment or Climate | 73 | 68 |
| Other Social Issues | 56 | 37 |
| Extraordinary Transactions | 37 | 0 |
| Shareholder Rights and Defenses | 17 | 7 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Bristol-Myers Squibb Company | May 5, 2026 | $146,839 | 15 | 1 |
| Merck & Co., Inc. | May 26, 2026 | $135,126 | 18 | 3 |
| Airbnb, Inc. | June 5, 2026 | $124,933 | 9 | 4 |
| Target Corporation | June 10, 2026 | $104,221 | 18 | 3 |
| Capital One Financial Corporation | May 8, 2026 | $100,294 | 16 | 1 |
| Omnicom Group Inc. | May 5, 2026 | $93,885 | 16 | 0 |
| Omnicom Group Inc. | January 28, 2026 | $93,885 | 1 | 0 |
| The PNC Financial Services Group, Inc. | April 22, 2026 | $90,021 | 16 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 5, 2026 | Bristol-Myers Squibb Company | Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| June 5, 2026 | Airbnb, Inc. | Oversight of risks relating to digital services; Shareholder proposal | Against | For |
| June 5, 2026 | Airbnb, Inc. | Report on discrimination in charitable support; Shareholder proposal | Against | For |
| June 10, 2026 | Target Corporation | Shareholder proposal requesting policy requiring the Board Chair to be an independent director. Shareholder proposal | For | Against |
| June 10, 2026 | Target Corporation | Shareholder proposal requesting a report on presence of pesticides in Target's private label brands. Shareholder proposal | Against | For |
| May 8, 2026 | Capital One Financial Corporation | Stockholder proposal to require a shareholder vote on golden parachute arrangements. Shareholder proposal | Against | For |
| May 19, 2026 | United Airlines Holdings, Inc. | Advisory vote on stockholder proposal entitled "Shareholder Right to Act by Written Consent". Shareholder proposal | For | Against |
| May 4, 2026 | Bank of America Corporation | Shareholder proposal requesting independent board chair Shareholder proposal | For | Against |
| May 4, 2026 | Bank of America Corporation | Shareholder proposal requesting report on board oversight of risks related to animal welfare Shareholder proposal | Against | For |
| April 30, 2026 | Crown Holdings, Inc. | Consideration of a Shareholder proposal regarding Shareholder right to act by written consent. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (1 in 2025-2026), and how the fund voted the items on its ballot.
8,804 ballot items at 627 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, AQR CVX Fusion Fund (QCFIX) voted at 627 shareholder meetings of 611 companies, on 8,804 ballot items in all. Where management made a recommendation, the fund followed it on 96.7% of the items and voted against it 291 times. Its most frequent area of disagreement was corporate governance (132 of its votes against management). It voted FOR 28.7% of the 342 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than AQR's funds as a whole (95.0% against 93.7%). It voted the same way as most AQR funds on every item where a comparison was possible. 1 of its meetings was contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of AQR’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.